ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Singapore's GIC invests in German pharma company Cheplapharm

Sovereign wealth fund and Atlantic Park investing nearly $550m

Cheplapharm says it will use its latest funding to fuel growth.   © AP

CEBU, Philippines -- German pharmaceutical Cheplapharm says it has raised 550 million euros ($547 million) in structured investment from Singapore sovereign wealth fund GIC and Atlantic Park.

Atlantic Park is a joint venture between global growth equity company General Atlantic and credit-focused asset manager Iron Park Capital Partners.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more